Literature DB >> 9871502

Total plasma homocysteine as part of the routine aminogram by ion-exchange chromatography.

A Briddon1.   

Abstract

Ion-exchange chromatography (IEC) with ninhydrin post-column derivatisation is the only technique available for the assay of total, (free plus bound), cysteine and homocysteine which also enables the routine measurement of all other commonly occurring amino acids. IEC assay of total cysteine and homocysteine typically involves incubating buffered plasma for 60 minutes at 37 degrees C with dithiothreitol (DTT), but these assay conditions significantly extend total analysis time and compromise other amino acid values, notably glutamine and glutamate. However, it is possible to carry out the DTT reduction in plasma virtually instantaneously and without additional buffering, thus preserving the integrity of other diagnostically important amino acids. Assay precision is adequate for cardiovascular risk assessment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871502     DOI: 10.1007/bf01318862

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  3 in total

1.  Medium-term methionine supplementation increases plasma homocysteine but not ADMA and improves blood pressure control in rats fed a diet rich in protein and adequate in folate and choline.

Authors:  François Mariotti; Alexia Hammiche; Clémence Blouet; Sophie Daré; Daniel Tomé; Jean François Huneau
Journal:  Eur J Nutr       Date:  2006-09-01       Impact factor: 5.614

2.  A rationale for cystine supplementation in severe homocystinuria.

Authors:  P J Lee; A Briddon
Journal:  J Inherit Metab Dis       Date:  2006-12-20       Impact factor: 4.982

3.  Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress.

Authors:  Thomas D Nolin; M Elizabeth McMenamin; Jonathan Himmelfarb
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-21       Impact factor: 3.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.